Literature DB >> 18655895

Chronic stress plasticity in the hypothalamic paraventricular nucleus.

James P Herman1, Jonathan Flak, Ryan Jankord.   

Abstract

Proper integration and execution of the physiological stress response is essential for maintaining homoeostasis. Stress responses are controlled in large part by the paraventricular nucleus (PVN) of the hypothalamus, which contains three functionally distinct neural populations that modulate multiple stress effectors: (1) hypophysiotrophic PVN neurons that directly control the activity of the hypothalamic-pituitary-adrenocortical (HPA) axis; (2) magnocellular neurons and their secreted neurohypophysial peptides; and (3) brainstem and spinal cord projecting neurons that regulate autonomic function. Evidence for activation of PVN neurons during acute stress exposure demonstrates extensive involvement of all three effector systems. In addition, all PVN regions appear to participate in chronic stress responses. Within the hypophysiotrophic neurons, chronic stress leads to enhanced expression of secreted products, reduced expression of glucocorticoid receptor and GABA receptor subunits and enhanced glutamate receptor expression. In addition, there is evidence for chronic stress-induced morphological plasticity in these neurons, with chronic drive causing changes in cell size and altered GABAergic and glutamatergic innervation. The response of the magnocellular system varies with different chronic exposure paradigms, with changes in neurohypophysial peptide gene expression, peptide secretion and morphology seen primarily after intense stress exposure. The preautonomic cell groups are less well studied, but are likely to be associated with chronic stress-induced changes in cardiovascular function. Overall, the PVN is uniquely situated to coordinate responses of multiple stress effector systems in the face of prolonged stimulation, and likely plays a role in both adaptation and pathology associated with chronic stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655895      PMCID: PMC3641577          DOI: 10.1016/S0079-6123(08)00429-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  83 in total

1.  Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.

Authors:  P M Plotsky; P E Sawchenko
Journal:  Endocrinology       Date:  1987-04       Impact factor: 4.736

Review 2.  Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor.

Authors:  F A Antoni
Journal:  Endocr Rev       Date:  1986-11       Impact factor: 19.871

3.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei.

Authors:  L W Swanson; P E Sawchenko
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

4.  Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin.

Authors:  D M Gibbs; W Vale; J Rivier; S S Yen
Journal:  Life Sci       Date:  1984-06-04       Impact factor: 5.037

5.  Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress.

Authors:  P B Chappell; M A Smith; C D Kilts; G Bissette; J Ritchie; C Anderson; C B Nemeroff
Journal:  J Neurosci       Date:  1986-10       Impact factor: 6.167

6.  Magnocellular axons in passage through the median eminence release vasopressin.

Authors:  M C Holmes; F A Antoni; G Aguilera; K J Catt
Journal:  Nature       Date:  1986 Jan 23-29       Impact factor: 49.962

7.  Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity.

Authors:  P E Sawchenko
Journal:  J Neurosci       Date:  1987-04       Impact factor: 6.167

8.  Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy.

Authors:  K Kovács; J Z Kiss; G B Makara
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

9.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin.

Authors:  G E Gillies; E A Linton; P J Lowry
Journal:  Nature       Date:  1982-09-23       Impact factor: 49.962

10.  Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus.

Authors:  E T Cunningham; P E Sawchenko
Journal:  J Comp Neurol       Date:  1988-08-01       Impact factor: 3.215

View more
  53 in total

Review 1.  Integrated circuits and molecular components for stress and feeding: implications for eating disorders.

Authors:  J A Hardaway; N A Crowley; C M Bulik; T L Kash
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

Review 2.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

Review 3.  Sex, hormones, and stress: how they impact development and function of the carotid bodies and related reflexes.

Authors:  Vincent Joseph; Mary Behan; Richard Kinkead
Journal:  Respir Physiol Neurobiol       Date:  2012-07-08       Impact factor: 1.931

4.  Hypothalamic oxytocin mediates adaptation mechanism against chronic stress in rats.

Authors:  Jun Zheng; Reji Babygirija; Mehmet Bülbül; Diana Cerjak; Kirk Ludwig; Toku Takahashi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-05       Impact factor: 4.052

5.  Cocaine use in the past year is associated with altitude of residence.

Authors:  Kristen K Fiedler; Namkug Kim; Douglas G Kondo; Perry F Renshaw
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

6.  The effects of single and repeated exposure to 2.45 GHz radiofrequency fields on c-Fos protein expression in the paraventricular nucleus of rat hypothalamus.

Authors:  T Jorge-Mora; M J Misa-Agustiño; J A Rodríguez-González; F J Jorge-Barreiro; F J Ares-Pena; E López-Martín
Journal:  Neurochem Res       Date:  2011-08-05       Impact factor: 3.996

7.  Sensitization of the Hypothalamic-Pituitary-Adrenal Axis in a Male Rat Chronic Stress Model.

Authors:  Alier J Franco; Chun Chen; Tyler Scullen; Andrea Zsombok; Ahmed A Salahudeen; Shi Di; James P Herman; Jeffrey G Tasker
Journal:  Endocrinology       Date:  2016-04-07       Impact factor: 4.736

8.  Role of paraventricular nucleus-projecting norepinephrine/epinephrine neurons in acute and chronic stress.

Authors:  Jonathan N Flak; Brent Myers; Matia B Solomon; Jessica M McKlveen; Eric G Krause; James P Herman
Journal:  Eur J Neurosci       Date:  2014-04-26       Impact factor: 3.386

9.  Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory.

Authors:  Hila Abush; Irit Akirav
Journal:  Neuropsychopharmacology       Date:  2013-02-20       Impact factor: 7.853

10.  Social isolation alters hypothalamic pituitary adrenal axis activity after chronic variable stress in male C57BL/6 mice.

Authors:  Ashley L Heck; Julietta A Sheng; Alex M Miller; Sally A Stover; Natalie J Bales; Sarah M L Tan; Renata M Daniels; Theodore K Fleury; Robert J Handa
Journal:  Stress       Date:  2020-03-04       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.